LONGBOARD
LIVE

Serial Number

90232096

Owner

Arena Pharmaceuticals, Inc.

Attorney

Maren C. Perry

First Use Date

Mar 10, 2022

Filing Date

Oct 2, 2020

Add to watchlist:

No watchlists yet
View on USPTO

LONGBOARD Trademark

Serial Number: 90232096 • Registration: 6761470

LONGBOARD is a trademark filed by Arena Pharmaceuticals, Inc. on October 2, 2020. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

Arena Pharmaceuticals, Inc. (46 trademarks)

6166 Nancy Ridge Drive
San Diego, CA 92121

Entity Type: 03

LONGBOARD PHARMACEUTICALS, INC. (56 trademarks)

LA JOLLA, CA 92037

Entity Type: 03

Trademark Details

Filing Date

October 2, 2020

Registration Date

June 14, 2022

First Use Anywhere

March 10, 2022

First Use in Commerce

March 10, 2022

Published for Opposition

November 9, 2021

Goods & Services

Pharmaceutical preparations and pharmaceutical compounds for the treatment of disorders of the central nervous system

Providing medical information

Scientific and technological services, namely, medical research, scientific research and analysis in the field of pharmaceuticals and biomedicine; pharmaceutical and biomedical research services; scientific research in the fields of pharmaceutical preparations, clinical trials; pharmaceutical research and development; providing scientific research information in the fields of pharmaceuticals, biomedicine and clinical trials; research and development services in the fields of pharmaceuticals and biotechnology; scientific research and development; laboratory research, screening, evaluation, development and clinical testing of therapeutic compounds; scientific research, studies, and development in the field of pharmaceuticals; scientific research and development, namely, pharmaceutical discovery, process development relating to synthesis and scalability for active pharmaceutical ingredients, large scale synthesis of active pharmaceutical ingredients, and formulation development

Filing History

TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jun 17, 2025 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jun 17, 2025 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jun 17, 2025 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Jun 17, 2025 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Jun 17, 2025 COAR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jun 14, 2022 NRCC
REGISTERED-PRINCIPAL REGISTER
Jun 14, 2022 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
May 10, 2022 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
May 8, 2022 CNPR
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
May 5, 2022 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
May 5, 2022 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
May 5, 2022 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
May 5, 2022 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
May 5, 2022 COAR
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
May 4, 2022 ASGN
STATEMENT OF USE PROCESSING COMPLETE
May 4, 2022 SUPC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
May 2, 2022 AITU
USE AMENDMENT FILED
Apr 18, 2022 IUAF
TEAS STATEMENT OF USE RECEIVED
Apr 18, 2022 EISU
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jan 4, 2022 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Nov 9, 2021 NPUB
PUBLISHED FOR OPPOSITION
Nov 9, 2021 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Oct 20, 2021 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 1, 2021 CNSA
EXAMINER'S AMENDMENT ENTERED
Oct 1, 2021 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Oct 1, 2021 GNEN
EXAMINERS AMENDMENT E-MAILED
Oct 1, 2021 GNEA
EXAMINERS AMENDMENT -WRITTEN
Oct 1, 2021 CNEA
NOTIFICATION OF PRIORITY ACTION E-MAILED
Mar 4, 2021 GPRN
PRIORITY ACTION E-MAILED
Mar 4, 2021 GPRA
PRIORITY ACTION WRITTEN
Mar 4, 2021 CPRA
ASSIGNED TO EXAMINER
Mar 1, 2021 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 17, 2020 NWOS
NEW APPLICATION ENTERED
Oct 6, 2020 NWAP